2017
DOI: 10.1093/pm/pnx145
|View full text |Cite|
|
Sign up to set email alerts
|

Association of Interleukin-6 and Other Cytokines with Self-Reported Pain in Prostate Cancer Patients Receiving Chemotherapy

Abstract: These findings suggest that the cytokines, particularly IL-6, whose levels were elevated in the chemotherapy-treated patients may be involved in the pathophysiology of CIP, and that they might be potential new targets for pain control in cancer patients receiving chemotherapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
11
2

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(14 citation statements)
references
References 28 publications
1
11
2
Order By: Relevance
“…In the chemokine panel, IP-10 was elevated at one month and at one year, while MCP-1 was elevated at one month in the ZA group. Both IP-10 and MCP-1 have been linked to pain [26][27][28][29]. In animal models, ZA reduced the expression of a number of pro-inflammatory and angiogenic mediators, including MCP-1 [30], whereas in our study, MCP-1 was elevated in the ZA group.…”
Section: Discussioncontrasting
confidence: 57%
“…In the chemokine panel, IP-10 was elevated at one month and at one year, while MCP-1 was elevated at one month in the ZA group. Both IP-10 and MCP-1 have been linked to pain [26][27][28][29]. In animal models, ZA reduced the expression of a number of pro-inflammatory and angiogenic mediators, including MCP-1 [30], whereas in our study, MCP-1 was elevated in the ZA group.…”
Section: Discussioncontrasting
confidence: 57%
“…IL-8 levels in the TFP group also showed low levels throughout the postoperative period, although there were no statistically significant differences between the 2 groups. Both IL-6 and IL-8 have also been implicated in pain levels, and patients with high pain scores exhibited significantly increased levels of IL-6 and IL-8 2427. However, in this study, which compared TFP with constant intravenous fentanyl infusion rather than placebo normal saline, the pain score was similar between the 2 groups.…”
Section: Discussioncontrasting
confidence: 61%
“…Patients with aggressive or advanced disease are likely to have increased pain (triggering opioid prescribing) and shorter survival, confounding an independent association between opioids and survival. [6,[18][19][20][21][22] Symptomatic patients may also have worse Karnofsky Performance Status (KPS), (a measure of functional status), itself an independent predictor of survival. [4,[23][24][25][26] Long-term data exploring the association between pain, opioids and survival are limited, but it is vital to address this concern to more accurately judge the benefits and risks of opioids in advanced progressive disease.…”
Section: Introductionmentioning
confidence: 99%